High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
复制标题
高维分析描述了成功的免疫检查癌症治疗过程中髓样和淋巴室的重塑。
DOI:
10.1016/j.cell.2018.09.030
复制
发表时间:
2018-11-01
期刊:
影响因子:
64.5
通讯作者:
Artyomov MN
中科院分区:
文献类型:
--
作者:
Gubin MM;Esaulova E;Ward JP;Malkova ON;Runci D;Wong P;Noguchi T;Arthur CD;Meng W;Alspach E;Medrano RFV;Fronick C;Fehlings M;Newell EW;Fulton RS;Sheehan KCF;Oh ST;Schreiber RD;Artyomov MN
While current immune checkpoint therapy (ICT) mainly targets lymphoid cells, it is associated with a broader remodeling of the tumor micro-environment. Here, using complementary forms of high dimensional profiling, we define differences across all hematopoietic cells from syngeneic mouse tumors during unrestrained tumor growth or effective ICT. Unbiased assessment of gene expression of tumor infiltrating cells by single cell RNA sequencing (scRNAseq) and longitudinal assessment of cellular protein expression by mass cytometry (CyTOF) revealed significant remodeling of both the lymphoid and myeloid intratumoral compartments. Surprisingly, we observed multiple subpopulations of monocytes/macrophages, distinguishable by the markers CD206, CX3CR1, CD1d and iNOS, that change over time during ICT in a manner partially dependent on IFNγ. Our data support the hypothesis that this macrophage polarization/activation results from effects on circulatory monocytes and early macrophages entering tumors, rather than on pre-polarized mature intratumoral macrophages. Comprehensive changes in the tumor microenvironment during successful immune checkpoint therapy are profiled, implicating a key role for polarization of infiltrating macrophages in the anti-tumor immune milieu
登录
查看更多内容
影响因子:
64.5
作者:
Levine JH;Simonds EF;Bendall SC;Davis KL;Amir el-AD;Tadmor MD;Litvin O;Fienberg HG;Jager A;Zunder ER;Finck R;Gedman AL;Radtke I;Downing JR;Pe'er D;Nolan GP
通讯作者:
Nolan GP
影响因子:
64.8
作者:
Matsushita, Hirokazu;Vesely, Matthew D.;Koboldt, Daniel C.;Rickert, Charles G.;Uppaluri, Ravindra;Magrini, Vincent J.;Arthur, Cora D.;White, J. Michael;Chen, Yee-Shiuan;Shea, Lauren K.;Hundal, Jasreet;Wendl, Michael C.;Demeter, Ryan;Wylie, Todd;Allison, James P.;Smyth, Mark J.;Old, Lloyd J.;Mardis, Elaine R.;Schreiber, Robert D.
通讯作者:
Schreiber, Robert D.
影响因子:
64.8
作者:
Shankaran, V;Ikeda, H;Schreiber, RD
通讯作者:
Schreiber, RD
DOI:
10.1084/jem.20130579
发表时间:
2013-08-26
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Simpson TR;Li F;Montalvo-Ortiz W;Sepulveda MA;Bergerhoff K;Arce F;Roddie C;Henry JY;Yagita H;Wolchok JD;Peggs KS;Ravetch JV;Allison JP;Quezada SA
通讯作者:
Quezada SA
DOI:
10.1126/science.1252510
发表时间:
2014-05-23
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Franklin RA;Liao W;Sarkar A;Kim MV;Bivona MR;Liu K;Pamer EG;Li MO
通讯作者:
Li MO